您的位置: 首页 > 农业专利 > 详情页

predictive biomarker of response to treatment of nicotinic acetylcholine alpha 7 receptor activator
专利权人:
NOVARTIS AG
发明人:
BALTAZAR GOMEZ-MANCILLA,CRISTINA LOPEZ-LOPEZ,DOMINIK FEUERBACH,DONALD JOHNS,Kevin Hall MCAllister,LISA SANDFORD,MARKUS WEISS,NICOLE PEZOUS,YUNSHENG HE
申请号:
BR112015013771
公开号:
BR112015013771A2
申请日:
2013.12.09
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Summary "predictive biomarker of treatment response to nicotinic acetylcholine alpha 7 receptor activator treatment" The invention provides methods for predicting the degree of therapeutic response in an individual suffering from cognitive disabilities or disorders, psychotic and / or neurodegenerative disorders to treatment with a nicotinic alpha 7 receptor activator of acetylcholine.resumo “biomarcador preditivo de resposta ao tratamento de ativador do receptor alfa 7 nicotínico de acetilcolina” a invenção proporciona métodos para predizer o grau de resposta terapêutica em um indivíduo que sofre de deficiências ou disfunções cognitivas, transtornos psicóticos e/ou neurodegenerativos a um tratamento com um ativador do receptor alfa 7 nicotínico de acetilcolina.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充